Uptravi

List of products in the National Drug Code with proprietary name uptravi. Selexipag is used to treat high blood pressure in the lungs (pulmonary arterial hypertension-PAH). It is used to help slow down worsening of PAH and to decrease the chance of needing treatment in a hospital. Selexipag works by making it easier for blood to flow through the arteries in your lungs. This effect helps increase your ability to exercise.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Product Type
66215-602	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-604	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-606	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-608	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-610	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-612	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-614	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-616	Uptravi	Selexipag	Tablet, Coated	Oral	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug
66215-718	Uptravi	Selexipag	Injection, Powder, For Solution	Intravenous	Actelion Pharmaceuticals Us, Inc.	Human Prescription Drug